WAT:NYE-Waters Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 377.1

Change

+5.34 (+1.44)%

Market Cap

USD 10.92B

Volume

0.35M

Analyst Target

USD 210.31
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Waters Corp is an analytical instrument manufacturer. It designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+0.90 (+0.38%)

USD 165.08B
A Agilent Technologies Inc

+0.98 (+0.72%)

USD 38.75B
IQV IQVIA Holdings Inc

+3.37 (+1.69%)

USD 36.13B
LH Laboratory Corporation of Amer..

+5.18 (+2.25%)

USD 19.12B
DGX Quest Diagnostics Incorporated

+1.37 (+0.90%)

USD 17.09B
QGEN Qiagen NV

+0.16 (+0.36%)

USD 9.99B
CRL Charles River Laboratories

+0.22 (+0.12%)

USD 9.50B
VNRX Volitionrx Ltd

+0.02 (+3.30%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.02 (-2.64%)

USD 0.04B
MTD Mettler-Toledo International I..

+2.74 (+0.22%)

N/A

ETFs Containing WAT

IVEG iShares Emergent Food and.. 4.56 % 0.00 %

+0.03 (+0.32%)

USD 4.13M
GSCE:SW BNP Paribas Easy Energy &.. 2.67 % 0.00 %

N/A

USD 0.14B
GSCU:SW BNP Paribas Easy Energy &.. 2.67 % 0.00 %

+0.04 (+0.32%)

USD 0.13B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.52 % 0.00 %

+0.06 (+0.32%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.52 % 0.00 %

+0.10 (+0.32%)

N/A
HLTH:AU VanEck Global Healthcare .. 2.49 % 0.00 %

+0.01 (+0.32%)

USD 0.06B
IBB iShares Biotechnology ETF 2.21 % 0.47 %

+1.18 (+0.32%)

USD 6.53B
FIW First Trust Water ETF 0.00 % 0.55 %

-0.45 (0.32%)

N/A
PHO Invesco Water Resources E.. 0.00 % 0.60 %

-0.49 (0.32%)

USD 2.15B
PIO Invesco Global Water ETF 0.00 % 0.75 %

-0.10 (0.32%)

USD 0.26B
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.25 (+0.32%)

CAD 0.01B
EMEH:PA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

-0.02 (0.32%)

USD 0.05B
GSCU:PA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.01 (+0.32%)

USD 0.13B
EMEH:XETRA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

-0.02 (0.32%)

USD 0.11B
GSDE:XETRA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.02 (+0.32%)

USD 0.47B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.65% 54% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.65% 54% F 67% D+
Trailing 12 Months  
Capital Gain 20.97% 100% F 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.97% 100% F 75% C
Trailing 5 Years  
Capital Gain 66.60% 92% A 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.60% 92% A 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.26% 92% A 73% C
Dividend Return 14.26% 77% C+ 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 33.12% 31% F 31% F
Risk Adjusted Return 43.06% 69% C- 57% F
Market Capitalization 10.92B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.60 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector